Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kajikawa, M.
Right arrow Articles by Seino, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kajikawa, M.
Right arrow Articles by Seino, Y.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 51:2522-2529, 2002
© 2002 by the American Diabetes Association, Inc.

Ouabain Suppresses Glucose-Induced Mitochondrial ATP Production and Insulin Release by Generating Reactive Oxygen Species in Pancreatic Islets

Mariko Kajikawa, Shimpei Fujimoto, Yoshiyuki Tsuura, Eri Mukai, Tomomi Takeda, Yoshiyuki Hamamoto, Mihoko Takehiro, Jun Fujita, Yuichiro Yamada, and Yutaka Seino

From the Department of Metabolism and Clinical Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan

We examined the effects of reduced Na+/K+-ATPase activity on mitochondrial ATP production and insulin release from rat islets. Ouabain, an inhibitor of Na+/K+-ATPase, augmented 16.7 mmol/l glucose–induced insulin release in the early period but suppressed it after a delay of 20–30 min. Unexpectedly, the ATP content in an islet decreases in the presence of 16.7 mmol/l glucose when Na+/K+-ATPase activity is diminished by ouabain, despite the reduced consumption of ATP by the enzyme. Ouabain also suppressed the increment of ATP content produced by glucose even in Ca2+-depleted or Na+-depleted conditions. That mitochondrial membrane hyperpolarization and O2 consumption in islets exposed to 16.7 mmol/l glucose were suppressed by ouabain indicates that the glycoside inhibits mitochondrial respiration but does not produce uncoupling. Ouabain induced mitochondrial reactive oxygen species (ROS) production that was blocked by myxothiazol, an inhibitor of site III of the mitochondrial respiratory chain. An antioxidant, {alpha}-tocopherol, also blocked ouabain-induced ROS production as well as the suppressive effect of ouabain on ATP production and insulin release. However, ouabain did not directly affect the mitochondrial ATP production originating from succinate and ADP. These results indicate that ouabain suppresses mitochondrial ATP production by generating ROS via transduction, independently of the intracellular cationic alternation that may account in part for the suppressive effect on insulin secretion.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
W. Schoner and G. Scheiner-Bobis
Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth
Am J Physiol Cell Physiol, August 1, 2007; 293(2): C509 - C536.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
Y. Yamada, K. Miyawaki, K. Tsukiyama, N. Harada, C. Yamada, and Y. Seino
Pancreatic and Extrapancreatic Effects of Gastric Inhibitory Polypeptide
Diabetes, December 1, 2006; 55(Supplement_2): S86 - S91.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Nabe, S. Fujimoto, M. Shimodahira, R. Kominato, Y. Nishi, S. Funakoshi, E. Mukai, Y. Yamada, Y. Seino, and N. Inagaki
Diphenylhydantoin Suppresses Glucose-Induced Insulin Release by Decreasing Cytoplasmic H+ Concentration in Pancreatic Islets
Endocrinology, June 1, 2006; 147(6): 2717 - 2727.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Takehiro, S. Fujimoto, M. Shimodahira, D. Shimono, E. Mukai, K. Nabe, R. G. Radu, R. Kominato, Y. Aramaki, Y. Seino, et al.
Chronic exposure to {beta}-hydroxybutyrate inhibits glucose-induced insulin release from pancreatic islets by decreasing NADH contents
Am J Physiol Endocrinol Metab, February 1, 2005; 288(2): E372 - E380.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Bottino, A.N. Balamurugan, H. Tse, C. Thirunavukkarasu, X. Ge, J. Profozich, M. Milton, A. Ziegenfuss, M. Trucco, and J. D. Piganelli
Response of Human Islets to Isolation Stress and the Effect of Antioxidant Treatment
Diabetes, October 1, 2004; 53(10): 2559 - 2568.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
Z. Xie and T. Cai
Na+-K+-ATPase-Mediated Signal Transduction: From Protein Interaction to Cellular Function
Mol. Interv., May 1, 2003; 3(3): 157 - 168.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2002 by the American Diabetes Association.